Scott D. Rogers, M.P.H.
Public Health Advisor, Office of the Associate Director
National Institutes of Health
National Cancer Institute
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
9609 Medical Center Drive, Rm. 4E306, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
- Telephone: (240) 276-6932
- Fax: (240) 276-7921
- E-mail: firstname.lastname@example.org
- Genetic susceptibility to cancer
University of Miami
- B.S. - Microbiology
University of Minnesota
Mr. Rogers, with the Epidemiology and Genomics Research Program's (EGRP) Office of the Director (OAD), is Co-Project Officer for the Cancer Genetics Network and a member of its Steering Committee, and a Project Officer for the Cancer Family Registries Informatics Support Center. He is a member of NCI's Cohort Consortium Leadership Team and the Steering Committee for the Breast and Prostate Cancer Cohort Consortium. He also is a member of the Body Mass Index and Mortality Pooling Project.
Mr. Rogers coordinates grants management activities, serves as the principal EGRP person responsible for working with Division-level staff on grants policy and management issues, and communicates with staff across the Program on these issues. In 2006, he joined EGRP as a federal employee but had been working the previous two years under a contract as a Research Associate on the Alpha-Tocopherol Beta-Carotene (ATBC) Study, an NCI chemoprevention trial that investigated whether vitamin E and beta-carotene could protect smokers from lung cancer. This research experience enabled Mr. Rogers to collaborate with scientists in the Tobacco Control Research Branch of the Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Epidemiology and Genetics (DCEG), which is the intramural epidemiology component of NCI.
Prior to coming to work at NCI, Mr. Rogers was a Senior Scientist in the Department of Preventive Sciences, University of Minnesota, where he worked with a team studying chronic pain in patients with bone cancer and spinal cord injuries, and specialized in cellular imaging.